Tag: diagnostics

CENTOGENE N.V., a commercial-stage company focused on rare diseases that transforms real-world clinical and genetic data into actionable information for patients, physicians and pharmaceutical companies, has...

Discovery Life Sciences™ (Discovery) has acquired QualTek Molecular Laboratories (QualTek), a renowned provider of immunohistochemistry (IHC) services with CAP/CLIA-accredited and Good Laboratory Practice-(GLP) capable laboratories in California...

Biodesix, Inc., has completed acquisition of Oncimmune’s laboratory and incidental pulmonary nodule (IPN) malignancy test in the United States, further extending the company’s blood-based lung cancer...

Veracyte, Inc. has announced preliminary clinical data showing that the company’s non-invasive nasal swab test – the first of its kind – can enable early lung...

OpGen, Inc., and Curetis N.V., a developer of next-level molecular diagnostic solutions, have entered into a definitive agreement to combine the two companies’ businesses, subject to...

Predictive Technology Group, Inc., a leader in the use of data analytics for disease identification and subsequent precision therapeutic intervention, has announced that its wholly owned...

Interpace Diagnostics Group, Inc. has executed an agreement with the Helomics division of Predictive Oncology, a company focused on applying artificial intelligence to personalized medicine and...

Foundation Medicine, Inc. has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for LYNPARZA® (Olaparib)...

ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine and Ayala Pharmaceuticals, a clinical stage precision...

Veracyte, Inc., a leading genomic diagnostics company, has begun making its next-generation Percepta® Genomic Sequencing Classifier (GSC) available to physicians, providing them with expanded lung cancer...